The Foundation for Technological Innovation (FIT) has announced new Tech Grants supporting five Swiss Health Valley projects, worth CHF 100,000…

Cancer research thrives at the intersection of the laboratory and the clinic — where fundamental discoveries meet the realities of…

NewBiologix S.A., a Swiss biotechnology company pioneering stable cell line technologies for recombinant adeno-associated virus (rAAV) manufacturing, announced an agreement with Synastra…

La Tour Hospital announces the launch of a pilot partnership with Evidone SA, a Swiss Health Valley healthcare technology company…

A new meaningful partnership in the Swiss Health Valley! FluoSphera licenses Debiopharm’s AbYlink™ Technology for 3D antibody characterization while leveraging…

Biopôle SA is delighted to announce that Bewe has been awarded the Pre-Clinical Top-Up, marking the next phase of a…

Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug…

The Biopôle-based startup announced a $40M Series A funding round to build the automated lab for agentic biology, led by…

Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the…

Bruker Corporation (NASDAQ:BRKR) announced that it is expanding its strategic collaboration with Atinary Technologies Inc., and acquiring a minority stake…

Alcon, the Geneva-based global leader in eye care, announced on Monday evening that it is discontinuing its intraocular lens (IOL)…

Oculis Holding AG, a Zug-based biopharmaceutical company with operations in Lausanne, has had a decisive first two weeks of August…